138 related articles for article (PubMed ID: 17435994)
41. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
[TBL] [Abstract][Full Text] [Related]
42. [Infantile hepatic hemangioendothelioma. A multifocal, bilobular and asymptomatic case with spontaneous regression].
Araújo AR; Maciel I; Costa JC; Vieira A; Enes C; Santos Silva E
An Pediatr (Barc); 2008 May; 68(5):507-10. PubMed ID: 18447999
[TBL] [Abstract][Full Text] [Related]
43. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma.
Motosugi U; Bannas P; Sano K; Reeder SB
J Magn Reson Imaging; 2015 Feb; 41(2):251-65. PubMed ID: 25104398
[TBL] [Abstract][Full Text] [Related]
44. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
[TBL] [Abstract][Full Text] [Related]
45. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
46. Will CT take second billing to MR imaging for the diagnosis of hypervascular hepatocellular carcinomas hereafter?
Kanematsu M
Radiology; 2011 Aug; 260(2):607; author reply 607-8. PubMed ID: 21778455
[No Abstract] [Full Text] [Related]
47. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of double-arterial phase gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging compared with double-arterial phase multi-detector row helical computed tomography.
Akai H; Kiryu S; Takao H; Tajima T; Shibahara J; Imamura H; Kokudo N; Akahane M; Ohtomo K
J Comput Assist Tomogr; 2009; 33(6):887-92. PubMed ID: 19940656
[TBL] [Abstract][Full Text] [Related]
50. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
Hardie AD; Kizziah MK; Rissing MS
J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
[TBL] [Abstract][Full Text] [Related]
51. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
52. The usefulness of gadoxetic acid-enhanced dynamic magnetic resonance imaging in hepatocellular carcinoma: toward improved staging.
Choi SH; Byun JH; Kwon HJ; Ha HI; Lee SJ; Kim SY; Won HJ; Kim PN
Ann Surg Oncol; 2015 Mar; 22(3):819-25. PubMed ID: 25201507
[TBL] [Abstract][Full Text] [Related]
53. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
54. Neonatal hepatoblastoma: two cases posing a diagnostic dilemma, with a review of the literature.
Sallam A; Paes B; Bourgeois J
Am J Perinatol; 2005 Nov; 22(8):413-9. PubMed ID: 16283600
[TBL] [Abstract][Full Text] [Related]
55. Hepatic haemangioma: dynamic MRI using gadolinium-DTPA.
Ohtomo K; Itai Y; Yoshikawa K; Kokubo T; Yashiro N; Iio M
Eur J Radiol; 1987 Nov; 7(4):257-9. PubMed ID: 3691543
[TBL] [Abstract][Full Text] [Related]
56. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
[TBL] [Abstract][Full Text] [Related]
57. [Ultrasound and dynamic contrast-enhanced MR imaging of a multifocal hemangioendothelioma in an infant].
Recher S; Savoye-Collet C; Dacher JN
J Radiol; 2003 Feb; 84(2 Pt 1):152-4. PubMed ID: 12717288
[TBL] [Abstract][Full Text] [Related]
58. Incremental diagnostic value of F-18 FDG PET/CT over MRI in a pediatric patient with suspected hepatoblastoma and histologic diagnosis of focal nodular hyperplasia.
Bertagna F; Orlando E; Bosio G; Bercich L; Fisogni S; Grazioli L; Giubbini R
Clin Nucl Med; 2011 Apr; 36(4):305-8. PubMed ID: 21368608
[No Abstract] [Full Text] [Related]
59. Epithelioid hemangioendothelioma of the liver: radiologic-pathologic correlation.
Mermuys K; Vanhoenacker PK; Roskams T; D'Haenens P; Van Hoe L
Abdom Imaging; 2004; 29(2):221-3. PubMed ID: 15290949
[TBL] [Abstract][Full Text] [Related]
60. CT of hypervascular hepatic tumors: are unenhanced scans necessary for diagnosis?
Patten RM; Byun JY; Freeny PC
AJR Am J Roentgenol; 1993 Nov; 161(5):979-84. PubMed ID: 8273641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
